Investing Profile
Noubar Afeyan
VC
Your Intro Paths to Noubar Afeyan
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Noubar is a member of
Massachusetts Institute of Technology Network
177 CONNECTIONS
McGill University Network
41 CONNECTIONS
Flagship Pioneering Network
20 CONNECTIONS
Find Noubar Afeyan on
cbCurrent Investing Position
Flagship Ventures Managing Partner
Investments On Record
50
Current Fund Size
$824M
Noubar Afeyan is on these Sector & Stage Rankings
Noubar Afeyan's Investments On Record (25)
Company | StageDateRound Size | Total Raised |
---|---|---|
Prologue Medicines | Series AMay 2024$50M | $50M |
Quotient Therapeutics | SeedNov 2023$50M | $50M |
Generate Biomedicines | Series CSep 2023$270M Series BNov 2021$370M | $640M |
Alltrna | Series BAug 2023$110M Series UnknownNov 2021$50M | $160M |
Empress Therapeutics | Series UnknownJun 2023$50M | $50M |
Metaphore Biotechnologies | UndisclosedMay 2023$50M | $50M |
Cellarity | Series COct 2022$120M Series BFeb 2021$120M | $240M |
Senda Biosciences | Series CAug 2022$120M Series AOct 2020$88M | $210M |
Noubar Afeyan's Experience
Co-Founder Indigo2013 - Present
Chairman and Co-Founder Moderna Therapeutics2010 - Present
Chairman and Co-Founder Axcella Health2010 - Present
Founder, CEO and Senior Managing Partner Flagship Pioneering2000 - Present
Chairman and Co-Founder Joule Unlimited Technologies, Inc.2007 - 2017
Chairman and Co-Founder Ensemble Therapeutics Corporation2002 - 2016
Senior Lecturer MIT Sloan School of Management2000 - 2016
CEO and Founder PerSeptive Biosystems1989 - 2008
Chairman and Co-founder Codon Devices2004 - 2007
Co-founder Epitome Biosystems2003 - 2005
Chief Business Officer Applera Corporation1998 - 1999
Co-Founder Celera Genomics1998 - 1999
Chairman and Co-Founder Chemgenics Pharmaceuticals1995 - 1997
Noubar Afeyan's Education
Massachusetts Institute of Technology PhD Biochemical Engineering
McGill University BS Chemical Engineering
Investors who invest with Noubar Afeyan